Alison A. Cornell, Director at Zivo Bioscience, Inc. (ZIVO), bought 11,990 shares at $0.08 ($1000) on 2024-08-22, disclosed to the SEC on 2024-08-23.
Open-market purchase of $1,000 ZIVO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| ZIVO | BUY | 2024-01-04 | $50K | — | Filing → |
| ZIVO | BUY | 2022-12-14 | $36K | — | Filing → |
| ZIVO | BUY | 2021-06-04 | $75K | — | Filing → |